Xencor Inc (XNCR)
18.37
-0.61
(-3.21%)
USD |
NASDAQ |
Apr 19, 16:00
18.37
0.00 (0.00%)
After-Hours: 20:00
Xencor Revenue (Quarterly): 44.69M for Dec. 31, 2023
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 44.69M |
| September 30, 2023 | 59.16M |
| June 30, 2023 | 45.52M |
| March 31, 2023 | 18.96M |
| December 31, 2022 | 21.61M |
| September 30, 2022 | 27.30M |
| June 30, 2022 | 30.18M |
| March 31, 2022 | 85.50M |
| December 31, 2021 | 154.02M |
| September 30, 2021 | 19.68M |
| June 30, 2021 | 67.45M |
| March 31, 2021 | 33.96M |
| December 31, 2020 | 41.85M |
| September 30, 2020 | 35.37M |
| June 30, 2020 | 13.09M |
| March 31, 2020 | 32.38M |
| December 31, 2019 | 3.516M |
| September 30, 2019 | 21.76M |
| June 30, 2019 | 19.48M |
| March 31, 2019 | 111.94M |
| December 31, 2018 | 11.56M |
| September 30, 2018 | 29.04M |
| June 30, 2018 |
| Date | Value |
|---|---|
| March 31, 2018 | |
| December 31, 2017 | 30.15M |
| September 30, 2017 | |
| June 30, 2017 | 12.50M |
| March 31, 2017 | 3.50M |
| December 31, 2016 | 27.94M |
| September 30, 2016 | 7.821M |
| June 30, 2016 | 66.01M |
| March 31, 2016 | 7.252M |
| December 31, 2015 | 21.75M |
| September 30, 2015 | 3.503M |
| June 30, 2015 | 1.014M |
| March 31, 2015 | 1.491M |
| December 31, 2014 | 5.664M |
| September 30, 2014 | 0.848M |
| June 30, 2014 | 0.824M |
| March 31, 2014 | 2.184M |
| December 31, 2013 | 1.744M |
| September 30, 2013 | 3.162M |
| June 30, 2013 | 3.921M |
| March 31, 2013 | 1.345M |
| December 31, 2012 | 2.425M |
| September 30, 2012 | 1.576M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
3.516M
Minimum
Dec 2019
154.02M
Maximum
Dec 2021
40.81M
Average
32.38M
Median
Mar 2020
Revenue (Quarterly) Benchmarks
| Ionis Pharmaceuticals Inc | 324.50M |
| Karyopharm Therapeutics Inc | 33.75M |
| NovaBay Pharmaceuticals Inc | 3.727M |
| Palatin Technologies Inc | 2.034M |
| iBio Inc | -- |
Revenue (Quarterly) Related Metrics
| Net Income (Quarterly) | -19.10M |
| Total Expenses (Quarterly) | 79.70M |
| EPS Diluted (Quarterly) | -0.31 |
| Enterprise Value | 587.65M |
| Profit Margin (Quarterly) | -42.74% |
| Earnings Yield | -11.43% |
| Normalized Earnings Yield | -11.14 |